scholarly journals Preclinical Pharmacokinetics and Biodistribution of Anticancer Dinuclear Palladium(II)-Spermine Complex (Pd2Spm) in Mice

2021 ◽  
Vol 14 (2) ◽  
pp. 173
Author(s):  
Martin Vojtek ◽  
Salomé Gonçalves-Monteiro ◽  
Edgar Pinto ◽  
Sára Kalivodová ◽  
Agostinho Almeida ◽  
...  
Keyword(s):  
Adipose Tissue ◽  
Half Life ◽  
Inductively Coupled Plasma ◽  
Mammary Glands ◽  
Preclinical Pharmacokinetics ◽  
Inductively Coupled ◽  
Terminal Half Life ◽  
Plasma Mass Spectrometry ◽  
Kidney Liver

Palladium-based compounds are regarded as potential analogs to platinum anticancer drugs with improved properties. The present study assessed the pharmacokinetics and biodistribution of a dinuclear palladium(II)-spermine chelate (Pd2Spm), which has previously been shown to possess promising in vitro activity against several therapy-resistant cancers. Using inductively coupled plasma-mass spectrometry, the kinetic profiles of palladium/platinum in serum, serum ultrafiltrate and tissues (kidney, liver, brain, heart, lungs, ovaries, adipose tissue and mammary glands) were studied in healthy female Balb/c mice after a single intraperitoneal bolus injection of Pd2Spm (3 mg/kg bw) or cisplatin (3.5 mg/kg bw) between 0.5 and 48 h post-injection. Palladium in serum exhibited biphasic kinetics with a terminal half-life of 20.7 h, while the free palladium in serum ultrafiltrate showed a higher terminal half-life than platinum (35.5 versus 31.5 h). Palladium was distributed throughout most of the tissues except for the brain, with the highest values in the kidney, followed by the liver, lungs, ovaries, adipose tissue and mammary glands. The in vitro cellular accumulation was also evaluated in breast cancer cells, evidencing a passive diffusion as a mechanism of Pd2Spm’s cellular entry. This study reports, for the first time, the favorable pharmacokinetics and biodistribution of Pd2Spm, which may become a promising pharmacological agent for cancer treatment.

Evaluation of the nanodebris produced by in vitro degradation of titanium-based dental implants in the presence of bacteria using single particle and single cell inductively coupled plasma mass spectrometry.

2021 ◽  
Author(s):  
Marzia Cosmi ◽  
Nathaly Gonzalez-Quiñonez ◽  
Pablo Tejerina Díaz ◽  
Ángel Manteca ◽  
Elisa Blanco González ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Dental Implants ◽  
Inductively Coupled Plasma ◽  
Metallic Materials ◽  
In Vitro Degradation ◽  
Inductively Coupled ◽  
Oral Environment ◽  
Plasma Mass Spectrometry ◽  
Materials Used

The bio-tribocorrosion of metallic materials used for dental implants (Ti and alloys) in the oral environment involves the production of metallic debris in the ionic, but also in the nanoparticulated...

scholarly journals High Precision Half‑Life Measurement of the Extinct Radio‑Lanthanide Dysprosium-154

2021 ◽  
Author(s):  
Nadine Mariel Chiera ◽  
Rugard Dressler ◽  
Peter Sprung ◽  
Zeynep Talip ◽  
Dorothea Schumann
Keyword(s):  
Half Life ◽  
Inductively Coupled Plasma ◽  
Theoretical Calculations ◽  
Target Material ◽  
Disintegration Rate ◽  
Inductively Coupled ◽  
Alpha Emitter ◽  
Life Measurement ◽  
Plasma Mass Spectrometry ◽  
Correct Estimation

Abstract Sixty years after the discovery of 154Dy, the half-life of this pure alpha-emitter was re-measured. 154Dy was radiochemically separated from proton-irradiated tantalum samples. Sector field- and multicollector-inductively coupled plasma mass spectrometry were used to determine the amount of 154Dy retrieved. The disintegration rate of the radio-lanthanide was measured by means of α-spectrometry. The half-life value was determined as (1.33 ± 0.07)∙106 y, with an uncertainty reduced by a factor of ~10 compared to the currently adopted value of (3.0 ± 1.5)∙106 y. This precise half-life value is crucial for the correct estimation of p-process nucleosynthetic reactions in the lanthanide region, as well as for the safe disposal of irradiated target material from spallation facilities. As a first application of the half-life value found in this work, the excitation functions for the production of 154Dy in proton-irradiated Ta, Pb, and W targets were re-evaluated, which found to be in agreement with theoretical calculations.

Biocompatibility of Near-IR Sensitive Au-Based Nanoparticles as the Potential Drug Delivery Carriers

2007 ◽  
Vol 334-335 ◽  
pp. 1177-1180 ◽  
Author(s):  
Bin Zhang ◽  
Xiao Li Huang ◽  
Lei Ren ◽  
Qi Qing Zhang ◽  
Mei Chee Tan ◽  
...  
Keyword(s):  
Inductively Coupled Plasma ◽  
Near Infrared ◽  
Nih3t3 Cells ◽  
Inductively Coupled ◽  
Near Ir ◽  
Icp Ms ◽  
Plasma Mass Spectrometry ◽  
Good Biocompatibility

We successfully synthesized near infrared (NIR) sensitive Au(shell)-Au2S(core) nanoparticles, where Au2S dielectric core was encapsulated by a thin gold shell. The cytotoxicity in vitro and biodistribution in vivo of Au-Au2S nanoparticles was studied by using NIH3T3 cells and KM mice, respectively. The quantitative analysis of Au in each tissue of mice was done by using the Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Au-Au2S nanoparticles (< 300 μg/ml) showed good biocompatibility. Au-Au2S nanoparticles were preferentially taken up by the liver and spleen, and ultimately eliminated mostly in the feces.

Distribution and elimination of palladium in rats after 90-day oral administration

2010 ◽  
Vol 26 (3) ◽  
pp. 183-189 ◽  
Author(s):  
Ivo Iavicoli ◽  
Beatrice Bocca ◽  
Luca Fontana ◽  
Stefano Caimi ◽  
Antonio Bergamaschi ◽  
...  
Keyword(s):  
Oral Administration ◽  
Inductively Coupled Plasma ◽  
Dry Weight ◽  
Health Impact ◽  
The Body ◽  
Internal Organs ◽  
Inductively Coupled ◽  
Male Wistar Rats ◽  
Plasma Mass Spectrometry ◽  
Kidney Liver

This study determined the distribution in internal organs and the elimination routes in rats after oral administration of potassium hexachloro-palladate. Forty male Wistar rats were exposed for 90 days to 0, 10, 100 and 250 ng/mL of the palladium (Pd) salt in drinking water. Samples of urine and feces were collected on days 1, 30, 60 and 90, while organs (kidney, liver, lung, spleen and bones) and blood were collected at the end of the experiment. Quantification method was based on the sector-field inductively coupled plasma mass spectrometry. Results indicated that Pd ions were rapidly eliminated from the body. The principal excretion was through the feces (650 ± 72.7 ng/g dry weight, at the Pd dose of 250 ng/mL), but at the higher dosing Pd was also eliminated through the urine (6.16 ± 1.91 ng/mL for the Pd intake of 250 ng/mL). A clear relationship between the Pd ingested dose and the Pd excretion amount was observed mainly in the feces. Absorbed Pd was mostly found in the kidney of rats (124.4 ± 23.0 ng/g dry weight, following the highest dose), while liver, lung, spleen and bones did not accumulate the metal. At the higher dosing, Pd content in the kidney raised proportionally with the Pd dose. Our findings may be useful to help in the understanding of the health impact of Pd dispersed in the environment as well as in identifying appropriate biological indices of Pd exposure.

Sign in / Sign up

Export Citation Format

Share Document